CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $265,000 | -84.5% | 15,764 | -78.9% | 0.00% | -100.0% |
| Q1 2018 | $1,714,000 | -11.5% | 74,839 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $1,936,000 | +75.4% | 74,839 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $1,104,000 | +5.7% | 74,839 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,044,000 | +37.9% | 74,839 | +68.7% | 0.00% | +100.0% |
| Q1 2017 | $757,000 | +103.5% | 44,363 | +22.7% | 0.00% | 0.0% |
| Q4 2016 | $372,000 | +1.6% | 36,163 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $366,000 | -45.3% | 36,163 | -35.3% | 0.00% | 0.0% |
| Q2 2016 | $669,000 | -11.9% | 55,934 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $759,000 | -28.5% | 55,934 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,061,000 | +1.0% | 55,934 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,050,000 | – | 55,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |